Wimagine® implant wins award at CES in Las Vegas!
The Wimagine implant, designed at Clinatec using a brain-computer interface (BCI), won an Innovation Award at the major international Consumer Electronics Show (CES) in Las Vegas in the “Accessibility & Aging Tech” category. A wonderful recognition and showcase for Clinatec’s work.
Clinatec and the Wimagine® implant take off for Las Vegas!
Clinatec will be present at the Consumer Electronics Show (CES) in Las Vegas in the beginning of January 2024 to present, on the CEA stand, the Wimagine® brain implant technology developed for people with disabilities.
Magali Bartolomucci, December Talent of the Month
Magali joined the Fonds Clinatec on September 1, 2023 to strengthen the team working on photobiomodulation and more specifically on the KLESIA SomniBrain project, the aim of which is to measure the impact of photobiomodulation on sleep quality and study its preventive and curative effects in Parkinson’s disease.
Post-doctoral position in Neurosciences
The Fonds Clinatec is hiring a post-doctoral researcher in neurosciences
Annual Clinatec Patrons’ Evening
A look back at our annual Patrons’ Evening, held yesterday, Thursday November 23 in Paris.
A new visual identity for the Fonds Clinatec
The year 2023 was a busy one for the Fonds Clinatec, with the arrival of a new CEO, Dr Laurent Hérault, a new President, Sophie Cluzel, and a Scientific Director, Prof. John Mitrofanis. As we approach our 10th anniversary, these changes reflect an evolution in the ambition of the Fonds Clinatec, which has adopted a […]
Kevin Paul, Fonds Clinatec talent for November
With two Masters degrees in Pharmaceutical Sciences and Physiology, Neuroscience and Behavior, Kevin joined the Fonds Clinatec in September 2023 to prepare a thesis in Neuroscience. His research project is part of the KLESIA SomniBrain project, which aims to use photobiomodulation to treat sleep disorders in Parkinson’s disease patients.
Scientific paper
Congratulations to Dr Jaimie Hoh Kam and Prof. John Mitrofanis who has recently published in Cells MDPI Journal, on the impact of glucose on modifying ATP and ROS levels in mouse fibroblast cell cultures by #photobiomodulation. This work was carried out as part of the major #CoveaNeurotec program on the #detection, #treatment and #prevention of […]